Cannabis Prohibition in South Asia During the 1920s
How diplomacy, not pharmacology, set cannabis's international legal status.
Cannabis wasn't actually banned worldwide in 1925—that's a popular myth. What happened was narrower: international trade in resin was restricted, and cannabis entered the League of Nations control framework. British India defended its existing tax-and-license system at Geneva, citing both cultural grounds (bhang was ritual) and revenue interests. Domestic prohibition in India didn't arrive until 1985.
South Asian cannabis policy in 1920: excise, not prohibition
Entering the 1920s, British India did not prohibit cannabis. Instead, it taxed and licensed it under provincial excise systems. Three products were regulated separately: ganja (dried flowering tops), charas (resin or hashish), and bhang (leaf preparation, typically consumed as a beverage). Each had its own tax rate, licensed vendors, and cultivation controls—most elaborate in Bengal, where a state-supervised ganja cultivation tract operated around Naogaon [1][2].
This regulatory framework rested on intellectual foundations laid by the Indian Hemp Drugs Commission Report (1894–1895), a seven-volume inquiry commissioned after questions raised in the British Parliament [2]. The Commission's central finding was that moderate cannabis use produced no significant physical, mental, or moral harm, and that prohibition would be unjustified, unenforceable, and likely to drive users toward alcohol or more dangerous substances [2]. Strong evidence This conclusion shaped the Government of India's official position for the next thirty years.
Bhang held particular importance: it was embedded in Hindu ritual observance, especially during Holi and Shivaratri festivals. Colonial administrators repeatedly warned London that suppressing bhang would provoke religious backlash and was administratively impractical [1][2]. Strong evidence
Geneva 1924–1925: how cannabis entered international drug law
Cannabis was not on the original agenda of the Second Opium Conference, convened by the League of Nations in Geneva in November 1924. It was added following intervention by a single delegation.
On 12 November 1924, the Egyptian delegate Mohamed El Guindy submitted a memorandum arguing that hashish posed a grave public health threat [3][4]. He claimed—without controlled epidemiological evidence—that chronic hashish use caused insanity and that a substantial share of inmates in Egyptian asylums were hashish users [3][4]. El Guindy proposed that 'Indian hemp' be added to the list of internationally controlled substances. Turkey supported the Egyptian position [3]. Weak / limited — El Guindy's claims relied on hospital admission data without control groups, base-rate correction, or standardized diagnostic criteria, and were contradicted by the earlier Indian Hemp Drugs Commission findings.
The British Indian delegation, led by John Campbell, opposed inclusion [3][4]. Campbell argued that bhang was a traditional and largely benign beverage, that domestic suppression was culturally and administratively unfeasible, and that international bodies should not dictate India's internal excise policy [3][4]. Strong evidence Historians including James Mills have documented that this principled position was accompanied by a straightforward material interest: cannabis excise revenues constituted a meaningful budget line for several Indian provinces [1]. Strong evidence The British position thus blended genuine cultural and administrative concerns with fiscal considerations.
The International Opium Convention, signed on 19 February 1925, embodied a compromise [5]:
- Cannabis resin ('charas') and preparations derived from it were added to the international control regime.
- International trade in Indian hemp was restricted to medical and scientific purposes.
- Cannabis leaves (bhang) were explicitly exempted from these controls [5].
- Signatories were not required to prohibit domestic cultivation, sale, or use [5].
Thus the widespread claim that 'cannabis was banned worldwide in 1925' is inaccurate Disputed. What occurred was narrower: international trade in resin was restricted, and cannabis was formally placed within the League's drug-control architecture for the first time [5]. Strong evidence Domestic policy remained a matter for each state.
What changed in South Asia after 1925
In the immediate aftermath: little changed on the ground. British India ratified the 1925 Convention but continued operating its excise-based licensing system. Ganja shops remained open. Bhang stalls remained open. Charas imports from Central Asia (Yarkand, Bukhara) faced tighter customs scrutiny but were not eliminated [1][6]. Strong evidence
What the 1920s did accomplish was a crucial shift in the burden of justification. Before 1925, prohibition needed to be argued for. After 1925, cannabis was internationally classified alongside opium and coca, and Indian officials increasingly had to argue why they were not prohibiting it. This ratchet continued tightening at each subsequent treaty: the 1931 Convention, the 1953 Opium Protocol, and finally the 1961 Single Convention on Narcotic Drugs, which placed cannabis into Schedule I and Schedule IV [7]. Strong evidence
India negotiated a 25-year transition period in the 1961 Single Convention that preserved traditional bhang use [7]. Domestic prohibition of ganja and charas in India did not arrive until the Narcotic Drugs and Psychotropic Substances Act of 1985—sixty years after Geneva [7]. Strong evidence Nepal's government-licensed hashish shops in Kathmandu operated until 1973, when they were closed under pressure from the United States Nixon administration [6]. Strong evidence
Myths that developed from this period
Several popular claims about this era are wrong or misleadingly simplified:
'The 1925 Geneva Convention banned cannabis.' It restricted international trade in resin and preparations, explicitly exempted leaves, and did not require domestic prohibition [5]. Disputed in popular sources, Strong evidence in the treaty text itself.
'The British banned cannabis in India in the 1920s.' They did not. They defended the existing excise system at Geneva and continued operating it for decades afterward [1][2]. Strong evidence
'Egypt's evidence was solid science.' El Guindy's claims about hashish and insanity relied on hospital admission records without control groups, diagnostic standardization, or adjustment for confounding factors [3][4]. These claims were contested at the time by the Indian Hemp Drugs Commission's more rigorous historical assessment [2]. Weak / limited
'The Indian Hemp Drugs Commission proved cannabis is safe.' The Commission concluded that the harms alleged by contemporaries were not being observed at the scale claimed, based on 1890s epidemiological and clinical methods [2]. It is a valuable historical document for understanding late-Victorian policy reasoning, not a modern clinical safety reference. Treat it as evidence about policy history, not current medical practice [2]. Strong evidence
The deeper pattern: diplomacy over pharmacology
The 1920s cannabis story reveals that international drug law was shaped less by pharmacological evidence than by diplomacy—by which delegations attended, what claims they made, what cultural or fiscal interests they defended, and what political leverage they possessed [1][3][4]. Strong evidence
Egypt's successful addition of cannabis to the international agenda, despite weak epidemiological support, contrasted with British India's ability to exempt bhang and preserve domestic autonomy despite fiscal incentives to harmonize globally. This was not a triumph of evidence; it was a negotiated outcome reflecting colonial power, religious accommodation, and revenue protection.
That inheritance—where cannabis's legal status is often determined by diplomatic history rather than updated pharmacology—still shapes global cannabis law today. Many of the arguments made at Geneva in 1924–1925 have been superseded by modern epidemiology and clinical research, yet the legal structures built on them remain remarkably durable.
Sources
- Book Mills, James H. (2003). Cannabis Britannica: Empire, Trade, and Prohibition, 1800–1928. Oxford University Press.
- Government Indian Hemp Drugs Commission (1894–1895). Report of the Indian Hemp Drugs Commission, 1893–94. Simla: Government Central Printing Office. 7 volumes.
- Peer-reviewed Kozma, Liat (2011). Cannabis Prohibition in Egypt, 1880–1939: From Local Ban to League of Nations Diplomacy. Middle Eastern Studies, 47(3), 443–460.
- Peer-reviewed Mills, James H. (2016). The Indian Hemp Drugs Commission and the making of global cannabis policy. Third World Quarterly, 37(2), 223–239.
- Government League of Nations (1925). International Opium Convention, signed at Geneva, 19 February 1925. League of Nations Treaty Series, Vol. 81.
- Peer-reviewed Chouvy, Pierre-Arnaud (2019). Cannabis cultivation in the world: heritages, trends and challenges. EchoGéo, 48.
- Government United Nations (1961). Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- 1961 Single Convention on Narcotic Drugs — The UN treaty that unified international drug control and shaped cannabis prohibition glob...
- Cannabis Culture in South Asia During the 1920s — How cannabis fit into colonial South Asian society, trade and tradition in the 1920s.
- Cannabis in 1920s America — The decade cannabis moved from pharmacy shelf to prohibition through state laws and sensat...
- UN Drug Treaties and Cannabis — Three UN treaties control cannabis globally; legalization exists despite treaty language f...